Announcement no. 56/2022
On
The purpose of the Program was to reduce the Company's share capital and adjust the capital structure by distributing capital to shareholders in line with the Company's Capital Structure and Capital Allocation Policy. The Program would end no later than
Following are the last transactions made under the Program in the period
Transactions | ||||
Date | No. of shares | Avg. purchase price in DKK | Transaction value in DKK | |
3,061 | 30.22 | 92,507 | ||
23,189 | 31.34 | 726,657 | ||
27,718 | 31.96 | 885,998 | ||
14,269 | 32.35 | 461,602 | ||
Total | 68,237 | 31.75 | 2,166,765 |
Össur acquired 2,000,000 shares under the Program at the average price of
The Program on Nasdaq Copenhagen was carried out in accordance with Regulation No. 596/2014 of the
Further information
Edda Lára Lúðvígsdóttir, Investor Relations Director, eludvigsdottir@ossur.com, +354 844 4759
Össur press releases by e-mail
If you wish to receive Össur press releases by e-mail, please register at http://www.ossur.com/investors
About Össur
Össur (Nasdaq Copenhagen: OSSR) is a global leader in non-invasive orthopaedics that helps people live a Life Without Limitations. A recognized "Technology Pioneer" with a rich 50-year history, Össur focuses on improving people's mobility through the delivery of innovative technologies in Prosthetics and Bracing & Supports. Significant investment in research and development have led to over 2,000 patents, award-winning designs, successful clinical outcomes, and consistently strong market positions. Össur is signatory to the
https://news.cision.com/ossur-hf-/r/ossur-hf--share-buyback-program-completed,c3644905
https://mb.cision.com/Main/18404/3644905/1636145.pdf
(c) 2022 Cision. All rights reserved., source